SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.48+0.5%9:49 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert K. who wrote (14766)9/20/2000 3:12:13 AM
From: manfredhasler  Read Replies (1) of 17367
 
Robert, Re: I expect answer from each.

Carefully. As has been done, i assume.

I guess I had more insisted on a close monitoring by the steering committee (DSMB). With the option to terminate the study prematurely (due to not foreseen problems) or change the protocol in the course of the study (maybe more difficult on a prospective manner).

As soon as it became evident that the first patients died due to logistic(?) problems the whole study design was to be questioned.

Regards,
Manfred
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext